KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $12,435,995 | +138.5% | 39,291 | +27.4% | 0.01% | +140.0% |
| Q3 2023 | $5,213,214 | -24.1% | 30,831 | -2.6% | 0.01% | -28.6% |
| Q2 2023 | $6,866,990 | +53.2% | 31,667 | +28.4% | 0.01% | +40.0% |
| Q1 2023 | $4,481,059 | -0.8% | 24,670 | +7.4% | 0.01% | 0.0% |
| Q4 2022 | $4,515,570 | -13.4% | 22,980 | -0.9% | 0.01% | -16.7% |
| Q3 2022 | $5,214,000 | +126.2% | 23,181 | +27.2% | 0.01% | +200.0% |
| Q2 2022 | $2,305,000 | -6.2% | 18,222 | -6.0% | 0.00% | 0.0% |
| Q1 2022 | $2,458,000 | +15.9% | 19,391 | +19.8% | 0.00% | +100.0% |
| Q4 2021 | $2,120,000 | +14.6% | 16,189 | +7.0% | 0.00% | 0.0% |
| Q3 2021 | $1,850,000 | +39.2% | 15,123 | +29.7% | 0.00% | 0.0% |
| Q2 2021 | $1,329,000 | -31.0% | 11,656 | -27.3% | 0.00% | 0.0% |
| Q1 2021 | $1,927,000 | -15.8% | 16,029 | -28.9% | 0.00% | 0.0% |
| Q4 2020 | $2,289,000 | +11.5% | 22,536 | -15.1% | 0.00% | 0.0% |
| Q3 2020 | $2,052,000 | -41.8% | 26,546 | -16.0% | 0.00% | -66.7% |
| Q2 2020 | $3,523,000 | – | 31,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |